MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 24 05 2018
revised: 02 11 2018
accepted: 10 01 2019
pubmed: 20 1 2019
medline: 1 1 2020
entrez: 20 1 2019
Statut: ppublish

Résumé

The mechanisms by which breast cancers progress from relatively indolent ductal carcinoma

Identifiants

pubmed: 30659022
pii: 0008-5472.CAN-18-1602
doi: 10.1158/0008-5472.CAN-18-1602
pmc: PMC6513674
mid: NIHMS1022476
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
NODAL protein, human 0
Nodal Protein 0
MKNK1 protein, human EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1646-1657

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207445
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA226567
Pays : United States
Organisme : CIHR
ID : PJT-156269
Pays : Canada
Organisme : CIHR
ID : MOP-142281
Pays : Canada

Informations de copyright

©2019 American Association for Cancer Research.

Références

Clin Transl Oncol. 2018 Mar;20(3):374-381
pubmed: 28766096
Oncogene. 2016 Jan 21;35(3):344-57
pubmed: 25893299
Nat Rev Cancer. 2007 Apr;7(4):246-55
pubmed: 17384580
J Biol Chem. 2014 Jan 17;289(3):1303-12
pubmed: 24297178
Biochem J. 2015 Apr 1;467(1):63-76
pubmed: 25588502
Biomol Concepts. 2015 Mar;6(1):85
pubmed: 25741793
J Cell Sci. 2012 Jun 15;125(Pt 12):2844-52
pubmed: 22454512
Nat Med. 2006 Aug;12(8):925-32
pubmed: 16892036
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):13984-90
pubmed: 20679220
Cancer Res. 2012 Aug 1;72(15):3851-63
pubmed: 22855743
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2298-307
pubmed: 23737503
Mol Cancer Res. 2016 Oct;14(10):984-993
pubmed: 27364770
Breast Cancer Res. 2009;11(5):R66
pubmed: 19735549
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11494-11499
pubmed: 29073077
Cancer Res. 2015 Mar 15;75(6):1102-12
pubmed: 25608710
Cancer Res. 2011 Mar 1;71(5):1849-57
pubmed: 21233335
Hum Pathol. 2013 Mar;44(3):402-11
pubmed: 23036368
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4153-4158
pubmed: 28377514
J Biol Chem. 1998 Apr 17;273(16):9373-7
pubmed: 9545260
Curr Stem Cell Res Ther. 2012 May;7(3):197-216
pubmed: 22329582
Mol Cell Biol. 1999 Mar;19(3):1871-80
pubmed: 10022874
Oncogene. 2013 May 23;32(21):2631-9
pubmed: 22777354
J Biol Chem. 2003 Nov 7;278(45):44197-204
pubmed: 12949082
Semin Cancer Biol. 2014 Dec;29:40-50
pubmed: 25073112
Cell Stem Cell. 2007 Nov;1(5):555-67
pubmed: 18371393
J Natl Cancer Inst. 2000 Jul 19;92(14):1185-6
pubmed: 10904098
Development. 2006 Jan;133(1):21-32
pubmed: 16319119
Histopathology. 2015 Oct;67(4):538-47
pubmed: 25728258
Mol Cell Biol. 2003 Aug;23(16):5692-705
pubmed: 12897141
J Clin Oncol. 1993 Oct;11(10):1929-35
pubmed: 8410120
Oncogene. 2014 Mar 20;33(12):1485-94
pubmed: 23584474
Cancer Metastasis Rev. 2016 Mar;35(1):21-39
pubmed: 26951550
Oncogene. 2014 Jan 23;33(4):461-73
pubmed: 23334323
Nat Rev Drug Discov. 2015 Apr;14(4):261-78
pubmed: 25743081
Cancer Biol Ther. 2010 Oct 1;10(7):728-35
pubmed: 20686366
J Clin Oncol. 2008 May 20;26(15):2568-81
pubmed: 18487574
Oncogene. 2015 Apr 16;34(16):2032-42
pubmed: 24909168
J Natl Cancer Inst. 2007 Apr 18;99(8):616-27
pubmed: 17440163
Cell Cycle. 2014;13(3):418-25
pubmed: 24247151
Breast Cancer Res. 2012 May 11;14(3):R75
pubmed: 22577960
Stem Cells. 2015 Feb;33(2):327-41
pubmed: 25187396
Cancer Cell. 2008 May;13(5):394-406
pubmed: 18455123
Genes Dev. 2007 Dec 15;21(24):3232-7
pubmed: 18055695
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Cancer Treat Rev. 2017 Apr;55:163-172
pubmed: 28402908
J Clin Invest. 2017 Nov 1;127(11):4179-4192
pubmed: 29035277
Dev Dyn. 2005 Apr;232(4):1031-6
pubmed: 15736223
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14134-9
pubmed: 20679199
Oncogene. 2013 Jun 6;32(23):2848-57
pubmed: 22797067
J Biol Chem. 2007 Feb 16;282(7):4243-52
pubmed: 17130135
Mod Pathol. 2010 Sep;23(9):1209-14
pubmed: 20495543
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
J Clin Invest. 2016 Jun 1;126(6):2181-90
pubmed: 27159396

Auteurs

Qianyu Guo (Q)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Vivian Z Li (VZ)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Jessica N Nichol (JN)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Fan Huang (F)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

William Yang (W)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Samuel E J Preston (SEJ)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Zahra Talat (Z)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Hanne Lefrère (H)

Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Henry Yu (H)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Guihua Zhang (G)

Cancer Research Institute of Northern Alberta, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

Mark Basik (M)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Christophe Gonçalves (C)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Yao Zhan (Y)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Dany Plourde (D)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Jie Su (J)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Jose Torres (J)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Maud Marques (M)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Sara Al Habyan (SA)

Goodman Cancer Centre, McGill University, Montréal, Québec, Canada.

Krikor Bijian (K)

Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Frédéric Amant (F)

Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Michael Witcher (M)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Fariba Behbod (F)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Centre, Kansas City, Kansas.

Luke McCaffrey (L)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Goodman Cancer Centre, McGill University, Montréal, Québec, Canada.

Moulay Alaoui-Jamali (M)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Nadia V Giannakopoulos (NV)

Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Muriel Brackstone (M)

Departments of Surgery and Oncology, Western University, London, Ontario, Canada.

Lynne-Marie Postovit (LM)

Cancer Research Institute of Northern Alberta, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Sonia V Del Rincón (SV)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada. wmiller@ldi.jgh.mcgill.ca sonia.delrincon@mcgill.ca.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Wilson H Miller (WH)

Division of Experimental Medicine, McGill University, Montréal, Québec, Canada. wmiller@ldi.jgh.mcgill.ca sonia.delrincon@mcgill.ca.
Department of Oncology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
Rossy Cancer Network, McGill University, Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH